drugset / Trial / NCT01821248

A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

NCT01821248 ↗

Phase 2 Unknown 25 enrolled Kansai Hepatobiliary Oncology Group
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and the safety of preoperative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis by FDG-PET.

Timeline

Start
2013-07-23
Primary completion
2016-09-27
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 25 mg/m2 —
Subject Gemcitabine Small molecule 1000 mg/m2 —
Subject S-1 Small molecule 100 unknown Oral

Indications